Latest updates for Ardx
Fresh curated links around ARDX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call Transcript
- Ardelyx President and CEO Sells 41,000 Shares for $243,000
- Accelerant (ARX) Q1 2026 Earnings Transcript
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Ardelyx President and CEO Sells 41,000 Shares for $243,000
This biotech innovator in gastrointestinal and kidney therapies reported a notable insider sale amid routine portfolio adjustments.
Accelerant (ARX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Jeffrey RadkeChief Financial Officer — Linda HuberHea...
Accelerant (ARX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Jeffrey RadkeChief Financial Officer — Linda HuberHea...
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
Arcutis Biotherapeutics, Inc. (ARQT) Q1 2026 Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript
Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers
Axonics
Axonics Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
argenx: The FcRn Franchise Is Becoming An Autoimmune Operating System
Akari locks arms with WuXi XDC to develop and manufacture novel ADC treatment
Oncology biotech Akari Therapeutics has announced a partnership with WuXi XDC, an antibody-drug conjugate (ADC) development and manufacturing company, to accelerate Akari’s drug de...
Axonics
Axonics Anonymous (not verified) Sat, 05/09/2026 - 08:22 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
<![CDATA[FDA Places Full Clinical Hold on Aardvark Therapeutics’ ARD-101]]>
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
Acurx (ACXP) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8 a.m. ETCALL PARTICIPANTSPresident & Chief Executive Officer — David P. LuciChief Financial Officer — Robert J. Sh...
Accuray Incorporated 2026 Q3 - Results - Earnings Call Presentation
Acurx (ACXP) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8 a.m. ETCALL PARTICIPANTSPresident & Chief Executive Officer — David P. LuciChief Financial Officer — Robert J. Sh...
NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
Applied Aerospace & Defense seeks $3.59 billion valuation in IPO
Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript
ARN Media Limited (ARNMF) Shareholder/Analyst Call Transcript
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.